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Abstract. A fatal disease epidemic affected the Bentiu area in southern Sudan and led
to a mass migration of the Nuer tribe searching for treatment. The initially available
information revealed a high mortality rate due to a possible occurrence of tuberculosis,
malaria, enteric fever or visceral leishmaniasis (VL). Serological screening of 53 of the most
severely affected patients in an enzyme-linked immunosorbent assay (ELISA) or an im
proved direct agglutination test (DAT) revealed positivity for VL. In 39 of those patients,
diagnosis was confirmed by identification of Leishmania donovani amastigotes in lymph
node or bone-marrow aspirates. In a total of 2714 patients observed, 1195 (44.0%) had
clinical symptoms suggesting VL: DAT positive titers (l:3200- 1:12800) were obtained
in 654 (24.1%), of whom 325 were confirmed parasitologically. Forty-two VL cases died
before or during treatment, giving a mortality rate of 6.4%. Among the intercurrent infec
tions diagnosed in the VL population (654), respiratory involvements (31.7%) and malaria
(10.7%) were most prevalent. With the exception of four (0.6%), all other VL patients (509)
responded readily to sodium stibogluconate. The factors initiating the outbreak are dis
cussed. Malnutrition and nomadic movements to potential VL endemic areas appeared to
be the most important. HIV infection as a possible predisposition seemed remote consid
ering the clinical and epidemiological similarity to VL occurring in East Africa, adequate
humoral response in DAT, and immediate positive response to specific anti-Leishmania
chemotherapy.
information it was also apparent that the disease
had not originated in Bentiu but was introduced
by nomads from the adjacent areas of Ayod and
Want. Considering the severe nature of the dis
ease involved, it was obvious that those who
succeeded in reaching Khartoum represented a
small proportion of the real number affected in
the main focus. The majority of the population
was dying along the migration route. The high
mortality among those who arrived in Khartoum
initiated investigations by our team to identify
and control the contagious disease. Hindered by
difficulty in reaching the main focus in Bentiu,
due to the continuous civil war in the region, our
efforts were concentrated on managing the dis
ease in the displaced population in Khartoum.
Similar measures were also undertaken for
thousands of others from the same tribe settled
in towns and villages along the 900- kilometer
migration route.
MATERIALS AND METHODS
Identification of the disease
Our first impression was that the killing dis
ease could be tuberculosis, enteric fever, chronic
The first case of visceral leishmaniasis (YL) in
the Sudan was diagnosed in 1904;' thereafter,
the endemic area was identified to be along the
bank of the Blue Nile and its tributaries (Fig. 1).
An outbreak among soldiers stationed in the
northern Upper Nile Province was reported thir
ty-six years later.2 The most famous outbreak
was in the period 1956â€”1958,involving the re
gion between the Blue and White Nile and Kas
sala Provinces up to the borders with Ethiopia.3
Among the tribes residing in this area, the Jum
Jum was most affected, having a mortality rate
of more than 50%.
In early October of 1988, we received the first
information of an outbreak of a killing disease
among migrants arriving in Khartoum from the
Bentiu area in the Upper Nile Province.4 The
outbreak had led to a mass migration of the Nuer
tribe to the northern towns of Kadugli, Kosti, El
Obeid and Khartoum seeking treatment. This
information indicated that the disease had not
only affected the Bentiu areabut also the adjacent
areas of Ayod, Adok and Want, and that the
mortality rate was extremely high among the
members of the Nuer tribe. On the basis of this
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Fiouar 1. Known endemic areas of visceral leishmaniasis in the Sudan. Scale: 1cm = 120kilometers.
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malaria or visceral leishmaniasis. Since African
trypanosomiasis has not been previously re
ported in Bentiu area and its typical clinical
symptoms were not observed in any of the pa
tients examined, it was excluded as a possible
infection in this epidemic.
Because of the unknown nature of the patho
gen involved, precautions were taken to prevent
its spread to the local community in Khartoum.
Due to the limited capacities of the hospitals
there, patients were visited at their settlements
around the city.
In order to identify the etiological agent, blood
and sputum samples were collected from the most
severely affected patients (53). Repeated blood
film examination for malaria parasites, Ziehi
neelsen staining for identification of acid-fast
Mycobacteria, or the Widal test for detection of
antibodies to Salmonella sp. were performed.
Blood and serum samples from those patients
were also tested in ELISA (10) and DAT (53) for
detection of specific anti-Leishmania antibod
ies.5 6
Hospitalization and management
An emergency hospital was erected to comply
with the necessary precautions for performing
organ aspiration and administration of chemo
therapy. In order to cope with the expected pres
sure, temporary wards were constructed in dis
trict hospitals along the migration route to
Khartoum.
Before admission to the emergency hospital,
all administrative information and case histories
of each patient were registered. Clinical and he
matological examinations including body weight,
temperature, liver and spleen size were regularly
performed, and hematological parameters such
as hemoglobin concentration, and total and dif
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ferential leukocytic counts were determined when
required. At the attached laboratory blood films,
organ aspirates, sputum and fecal samples were
also examined. The DAT and ELISA for VL were
performed at Michigan State Laboratory in
Khartoum.
All patients received well-balanced diets to en
sure good response to treatment, and multivi
tamin supplements were administered regularly.
Diagnosis af VL
Out of 2714 persons examined for various
clinical disorders, 1195 were suspected for VL.
Prevalence of VL was also assessed in Nuer mi
grants from the same area (Bentiu) who had set
tled in Khartoum 6-12 months earlier, blood
specimens were collected from 343 persons ran
domly selected from two groups. As controls for
DAT performance, the following serum samples
were included: 18 healthy individuals (10 Dutch
and 8 Sudanese); 20 parasitologically confirmed
YL cases (10 Kenyans and 10 Sudanese); 45 Su
danese patients with confirmed malaria (15), tu
berculosis (18) or schistosomiasis (12).
Patients with clinical suspicion of VL and pos
itive DAT titers ( 1:3200) were subjected to
parasitological confirmation. Giemsa-stained as
pirates from enlarged lymph nodes (inguinal or
cervical glands) or bone-marrow (iliac crest) were
judged for presence of amastigotes by at least two
trained persons. Since we were not able to guar
antee the required safety measures in our pro
visory hospital, spleen and liver punctures were
not performed. The hemorrhagic signs and epi
staxis were additional contraindications. Taking
into account the size of the population to be
examined and the number of manipulations re
quired for its performance, bone-marrow aspi
ration was only done at the initial phase of our
investigations for confirmation of VL.
Patients suspected for VL were also assessed
for intercurrent infections such as tuberculosis,
malaria and other endemic diseases. When di
agnosed, patients with intercurrent infections
were treated simultaneously or after completion
of therapy against VL.
Justification of treatment
After confirmation of VL by lymph node as
piration, patients were put immediately on anti
Leishmania chemotherapy. Negative parasito
logical findings did not exclude suspicion for VL
since this method is known to be insensitive.
Culturing of aspirates, which might have had
improved sensitivity, was not manageable due
to the frequent microbial contamination, irreg
ular electric current for optimal incubation and
the very high laboratory temperature (30â€”35Â°C).
Delay in administration of anti-Leishmania
chemotherapy was considered risky as patients
were in extremely poor condition. Due to ashort
age of ELISA antigen and lack of facilities to
perform other serological tests, administration
of chemotherapy in the unconfirmed cases was
mainly based on clinical symptoms typifying YL,
and DAT-positive results. Reliance upon DAT
positivity was justified by the required sensitivity
and specificity experienced in 15 different en
demic areas of VL.6'Â°
Treatment procedures
Sodium stibogluconate (Pentostam) is consid
ered the most effective drug against East african
VL.â€￿The full dose schedule recommended by
WHO Expert Committee was followed: 10mg!
Kg body weight iv was prescribed for adults.
Children up to 12 years of age received daily
doses of 200â€”400mg respectively.'2
Before subjection to full course treatment, pa
tients were evaluated for positive responses in a
5-day therapeutic test starting with one-sixth of
the recommended dose, thereafter increasing
gradually to reach the full dosage on day 6. Initial
positive responses such as disappearance of fe
ver, physical improvement and absence of side
effects,justified full course treatment for 30 days.
At the time of this report, 513 out of 663 diag
nosed YL cases were treated according to the
regimen described above. The criteria consid
ered for successful treatment and subsequent dis
charge from the hospital were: disappearance of
fever, regression in spleen size, weight gain, ces
sation of hemorrhagic diathesis and improve
ments in general condition. Considering the large
number of VL cases, the hematological responses
were evaluated in only a few patients (30).
RESULTS
Of the first group of 500 patients examined,
the vast majority (98.9%) were from the Nuer
tribe. The incidence of the disease was slightly
higher in males (57%) and all age groups wereClinical conditionNumberof patientsUpper
respiratory tractinvolvements13620.8%Pneumonia6710.2%Tuberculosis40.6%Diarrhea12018.3%Malaria7010.7%Giardiasis172.6%Amoebiasis152.3%MucocutaneousLeishmaniasis71.1%
Clinical symptomNumber of patientsFever500100%Splenomegaly41983.8%Anemia16432.8%Hepatomegaly15831.6%Emaciation10220.4%Epistaxis377.4%Lymphadenopathy306.0%Hyperpigmentation20.4%
Total number
Diagnosis testedDAT
titer range5@1:4001:800-
1:1,6001:3,200- 1:6,400@1:l2,800Clinically
suspected for VL@ 1195
Randomly selected population@@ 343
Controlgroupwithotherinfections 45
Confirmed VL control group 20
Healthy individual control group 18503
328
44
0
1838
6
1
0
059
0
0
0
0595
9
0
20
0cut.ofltiter
- 1:3,200.
Patients from the affected population Nuer tribe under study. @ from the same tribe settled 6â€”12 months earlier in Khartoum.
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TABLE 1
Distribution ofclinical symptomsobserved inthe frst
500patients examined
TAm@n 3
Intercurrent infections identified in 654 VLpatients
affected: 40% were children younger than 15, 40%
in the 15â€”34 years of age group and 20% were
older than 35. The prevailing symptoms are pre
sented in Table 1.
The absence of tuberculosis, malaria, enteric
fever and African trypanosomiasis in the 53 most
severely affected patients indicated a higher
probability of VL. In 10 samples from this group
screened by both ELISA and DAT and in 43
screened by DAT only, results indicated VL (ab
sorbances 0.5 and titers 1:3200). The ser
opositivity to VL obtained by DAT and ELISA
in these 53 patients indicated that VL was most
likely to be the major â€œkilling diseaseâ€￿in this
epidemic. Leishmania donovani amastigotes were
demonstrated later by lymph node (29) or bone
marrow (10) aspiration in 39 of them. Although
in further diagnosis special emphasis was placed
on VL, the possible presence of other infections
was not excluded.
Of 2714 patients examined, 1195 (44.0%) had
clinical symptoms of YL. DAT-positive readings
(titers 1:3200) were obtained in 654 (24.1%);
L. donovani amastigotes were demonstrated in
325 of them. Titers ranging from 1:800â€”1:1600
were obtained in 38 patients with no obvious
symptoms of VL (Table 2). Forty-two confirmed
VL cases died before or during treatment, giving
a mortality rate of 6.4%.
In the seroprevalence survey carried out in the
randomly selected group (Table 2), nine individ
uals (2.6%) scored DAT titers indicative of YL.
Two of these nine were shortly afterwards di
agnosed by lymph node as VL cases. In the re
maining seven no YL symptoms were observed;
they were considered for a follow-up study not
yet completed.
Among the intercurrent infections diagnosed
in the VL population, respiratory tract involve
ments, diarrhea and malaria appeared to be the
most dominant (Table 3). Epistaxis was one of
the serious problems encountered in VL man
agement; 1â€”3 cases were seen daily. Its peak was
during the three hottest months of April, May
and June. Application of adrenalin-impregnated
gauze appeared to be effective in most of the
patients. In persistent cases, subjecting YL pa
tients to a cooler air current from a fan proved
to be helpful. Examination of blood smears from
those patients showed no Borrelia infection as
was first anticipated. As an additional precau
tion, acetylsalicylic acid was banned from the
hospital.
TABLE 2
DAT titer distribution for VL in clinically suspected and randomly selected populations from Bentiu area287 A KILLINGDISEASEEPIDEMIC
Almost all (509/513â€”99.4%)VL cases treated have also contributed in this YL outbreak. Pre
showed immediate positive response to Pentos
tam administration. Fever subsided during the
first week and an average decrease of 4.4 cm in
spleen size was observed during the course of
treatment. At the time of admission to the hos
pital, the average total leukocyte count was 2500
cells/mm3 and at the end of treatment this ranged
from 4000â€”12900cells/mm3. There was cessa
tion of epistaxis and hemorrhagic diathesis and
improvements in the general condition of the
treated patients. Primary unresponsivness was
seen in two VL cases; after a second course of
Pentostam they were cured. Two others did not
show improvements, even after a second course
of treatment; they were referred to the Academic
Hospital in Khartoum.
No major toxic side effects were observed dur
ing the course of treatment with Pentostam. Six
VL patients with cardiac dysfunction due to peri
carditisoranemicheartfailureweretreatedwith
out sequelae.
DISCUSSION
The factors that initiated this severe VL out
break are not yet fully understood. On the basis
of available information, VL was not among the
important endemic infections in this area. The
last devastating VL outbreak in the Sudan was
reported 32 years earlier in the Fung area, hun
dreds of kilometers east of Bentiu. However, the
affected population (Nuer tribe) are nomadic cat
tle owners. Their seasonal migration to the
northern part of this province or the southern
borders of the Blue Nile Province may have re
sulted in importation of the disease. Migration
movements from VL-endemic areas appear to
be most important in previous outbreaks that
had occurred in the Sudan. Of a similar mag
nitude were those reported in the southern Fung
and Melut areas, where VL was imported by no
madic Arabs of Ruffa El Hoi from Singa and
patrolling soldiers from Jongols post.23
The continuous civil war has destabilized the
agricultural activities, nomadic movements and
health services in this region. Likewise, trans
portation of food from the north and implemen
tation of health care measures including control
of malaria and VL were interrupted. The impli
cation of those deficiencies was clearly reflected
in the severe malnutrition signs in the population
studied. The combination of these factors may
vious studies have shown that VL can be latent
for very long periods, acquiring an overt clinical
form after exposure to stresses such as malnu
trition. â€˜ 3. @ To the best ofour knowledge, serious
intercurrent infections other than malaria, re
spiratory tract involvement or tuberculosis, were
not identified. In contrast to other studies where
HIV infection or auto-immune disorders oc
curred concurrently with VL,'5 all of our VL pa
tients with or without intercurrent infections re
sponded well to chemotherapy and proper
nourishment.
The positive DAT titers obtained in all YL
patients so tested exclude the possibility of im
munodeficiency as far as the humoral response
is concerned. In previous studies carried out in
southern France,7 two out of four patients with
positive HIV tests and confirmed VL showed
clearly negative DAT titers. The positivity of
DAT in the other two was attributed to an early
stage of HIV infection at which the humoral re
sponse is known to be still functional. For ethical
and social reasons we were not able to subject
some of our patients to an HIV test.
Since our efforts to reach Bentiu were not suc
cessful, the role played by the sand fly or that of
the animal reservoir in this VL outbreak remains
undetermined. Phlebotomus orientalis is the ma
jor vector for leishmaniasis in the south of Su
dan, and considering the favorable ecology of the
area, this species can be present in large num
bers.'6 Depending on the availability of the etil
ogic agent, L. donovani, and the prevailing cli
matological conditions, up to 4% of the
population can be infected.'7
Unlike the Mediterranean littoral where the
dog is known to be the major source of VL, ro
dents such as Rattus rattus and Avricanthis nil
oticus and carnivores including the cat and genet
have been incriminated as sources of VL in
southern Sudan.'7 Perhaps for reasons related to
the better standard of living, the very high in
cidence of leishmaniasis among the local dog
population in the Mediterranean does not cor
relate with that of VL in the human population.
Lowered immune responses due to malnutrition
in this affected population may have contributed
to an increased susceptibility to L. donovani
transmitted from the local animal reservoirs.
In spite of the severe nature of VL in this out
break, its epidemiological and clinical features
were not very much different from those reported288 DE BEER AND OTHERS
in East Africa.â€￿8 Males (57%)and children be
low 15 years of age (40%) were most affected.
The prevailing symptoms were also similar to
those reported in an earlier VL outbreak in the
adjacent Blue Nile province and in endemic ar
eas of K.enya.3â€￿Â° Epistaxis and hemorrhagic signs,
however, were common in our YL patients, pos
sibly due to the very high ambient temperatures.
Reliance on these symptoms did not guarantee
differential diagnosis with respect to other com
monly occurring diseases in the Sudan.3 In our
judgement, failure to properly diagnose VL at its
onset in Bentiu accounted for this high mortality.
In this epidemic the DAT was of great assis
tance in identification of VL. Its further use in
screening procedures provided the required re
liability and practicability under the adverse con
ditions experienced in Sudan. All patients who
had positive DAT titers ( 1:3200) were found
to be either genuine cases of VL or favorably
responding to specific anti-Leishmania chemo
therapy. While in 51.0% of the VL patients, no
L. donovani amastigotes could be demonstrated,
DAT titers ranged from 1:3200â€” 1:12800. Ad
ministration of Pentostam in 509 (99.2%) out of
513 hospitalized resulted in successful treatment.
The required specificity of DAT with respect to
infections clinically undistinguishable from VL
is evidenced in this as well as earlier studies un
dertaken in Kenya, Brazil and Sudan.6'9â€￿Â° Hav
ing experienced the devastating effects on this
displaced population, we conclude that regular
epidemiologic and surveillance procedures are
imperative in order to overcome future VL out
breaks.
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